Article
Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors.
BMC biotechnology - 22 Mar 2010
Arslanova Dilyara, Yang Ting, Xu Xiaoyin, Wong Stephen T, Augelli-Szafran Corinne E, Xia Weiming
Abstract excerpt
BACKGROUND: Several gamma-secretase inhibitors (GSI) are in clinical trials for the treatment of Alzheimer's disease (AD). This enzyme mediates the proteolytic cleavage of amyloid precursor protein (APP) to generate amyloid beta protein, Abeta, the pathogenic protein in AD. The gamma-secretase also cleaves Notch to generate Notch Intracellular domain (NICD), the signaling molecule that is implicated in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
